AR
GWPH

Advisory Research’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Advisory Research’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,466
Closed -$661K – 466
2017
Q1 		$661K Buy
+5,466
New +$671K 0.01% 346

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Advisory Research's GWPH Position: Q2 2017 in Review

Advisory Research sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 5,466 shares — an estimated $661K sold.

Advisory Research first reported a position in GWPH in Q1 2017 and held it in 1 quarter. The position peaked at $661K in Q1 2017. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • Advisory Research reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
  • Advisory Research sold 5,466 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $661K.
  • Advisory Research first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 1 quarter.
  • Advisory Research's GW Pharmaceuticals Plc American Depositary Shares position peaked at $661K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on Advisory Research's 13F filing for Q2 2017, filed 14 Aug 2017.